Search

Your search keyword '"R. Cuvelier"' showing total 105 results
Start Over Author "R. Cuvelier"
105 results on '"R. Cuvelier"'

1. DIALYSIS. PATHOPHYSIOLOGY AND CLINICAL STUDIES

Author

J. K. Humalda, S. Assa, G. J. Navis, C. F. M. Franssen, M. H. De Borst, H. Ogawa, Y. Ota, T. Watanabe, Y. Watanabe, H. Nishii, A. Sato, J. Waniewski, M. Debowska, A. Wojcik-Zaluska, A. Ksiazek, W. Zaluska, C. M. Guastoni, C. Turri, L. Toma, G. Rombola, G. Frattini, G. Romei Longhena, U. Teatini, D.-C. Siriopol, S. Stuard, A. Ciolan, G. Mircescu, D. Raluca, I. Nistor, A. Covic, C. L. De Roij Van Zuijdewijn, I. Chapdelaine, M. J. Nube, P. J. Blankestijn, M. L. Bots, S. J. Konings, M. A. Van Den Dorpel, N. C. Van Der Weerd, P. M. Ter Wee, M. P. Grooteman, P. S. Djuric, A. Jankovic, J. Tosic, S. Bajcetic, T. Damjanovic, J. Popovic, N. Dimkovic, J. Marinkovic, Z. Djuric, V. Knezevic, T. Lazarevic, S. Ljubenovic, R. Markovic, V. Rabrenovic, L. Djukanovic, V. Radovic Maslarevic, V. Mathrani, P. Drew, J. I. Chess, A. I. Williams, S. Robertson, M. Jibani, V. I. Aithal, M. Kumwenda, G. Roberts, A. I. Mikhail, A. E. Grzegorzewska, G. Ostromecki, A. Mostowska, A. Sowi ska, P. P. Jagodzi ski, H.-Y. Wu, H.-Y. Chen, S.-P. Hsu, M.-F. Pai, J.-Y. Yang, Y.-S. Peng, M. Hirose, T. Hasegawa, N. Kaneshima, F. Sasai, D. Komukai, K. Takahashi, F. Koiwa, K. Shishido, A. Yoshimura, G. Selim, O. Stojceva-Taneva, L. Tozija, P. Dzekova-Vidimliski, L. Trajceska, Z. Petronievic, S. Gelev, V. Amitov, A. Sikole, S. J. Moon, S. Y. Yoon, D. H. Shin, J. E. Lee, H.-J. Kim, H.-C. Park, D. Hadjiyannakos, V. Filiopoulos, G. Loukas, S. Pagonis, C. Andriopoulos, A. Drakou, D. Vlassopoulos, C. Catarino, P. Cunha, S. Ribeiro, P. Rocha-Pereira, F. Reis, M. Sameiro-Faria, V. Miranda, E. Bronze-Rocha, L. Belo, E. Costa, A. Santos-Silva, A. De Mauri, M. Brambilla, D. Chiarinotti, D. Lizio, R. Matheoud, N. Conti, M. M. Conte, A. Carriero, M. De Leo, A. V. Karpetas, P. A. Sarafidis, P. I. Georgianos, G. Koutroumpas, D. Divanis, P. Vakianis, G. Tzanis, K. Raptopoulou, A. Protogerou, D. Stamatiadis, C. Syrganis, V. Liakopoulos, G. Efstratiadis, A. N. Lasaridis, M. Tersi, D. N. Stamatiadis, P. Kuczera, M. Adamczak, A. Wiecek, S. Bove, B. Giacon, R. Corradini, E. Prati, M. Brognoli, A. Tommasi, L. Sereni, G. Palladino, H. Moriya, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, S. Hidaka, T. Ohtake, S. Kobayashi, A. Moura, J. Madureira, P. Alija, J. C. Fernandes, J. G. Oliveira, M. Lopez, M. Filgueiras, L. Amado, M. Vieira, J.-H. Seok, H. Y. Choi, S. K. Ha, H. C. Park, M. Bossola, A. Laudisio, M. Antocicco, L. Tazza, G. Colloca, M. Tosato, G. Zuccala, E. M. Ettema, J. Kuipers, H. Groen, R. T. Gansevoort, K. Stade, S. J. L. Bakker, C. A. J. M. Gaillard, R. Westerhuis, J. Bacchetta, K. Couchoud, S. Semlali, A.-L. Sellier-Leclerc, A. Bertholet-Thomas, R. Cartier, P. Cochat, B. Ranchin, J. C. Kim, K. Park, C. Van Ende, D. Wilmes, F. E. Lecouvet, L. Labriola, R. Cuvelier, G. Van Ingelgem, M. Jadoul, C. Doriana, P. David, F. Capurro, M. Brustia, C. E. Ruva, S. Giungi, E. Di Stasio, S. Lemesch, B. Leber, A. Horvath, W. Ribitsch, G. Schilcher, G. Zettel, M. Tawdrous, A. R. Rosenkranz, V. Stadlbauer-Kollner, H. Matsushima, A. Oyama, E. Bosch Benitez-Parodi, E. Baamonde Laborda, F. Batista Garcia, G. Perez Suarez, G. Anton Perez, C. Garcia Canton, A. Toledo Gonzalez, M. M. Lago Alonso, M. D. Checa Andres, G. Cobo, C. Di Gioia, R. Camacho, C. Garcia Lacalle, O. Ortega, I. Rodriguez, J. Herrero, A. Oliet, M. Ortiz, C. Mon, A. Vigil, P. Gallar, V. Pellu, P. E. Nebiolo, K. Sasaki, S. Yamguchi, A. Hesaka, E. Iwahashi, S. Sakai, T. Fujimoto, S. Minami, Y. Fujita, K. Yokoyama, E. Shutov, G. Ryabinskya, S. Lashutin, E. Gorelova, E. Volodicheva, M. A. Podesta, G. Cancarini, D. Cucchiari, A. Montanelli, S. Badalamenti, G. Graziani, E. Distasio, I. Pchelin, A. Shishkin, Y. Fedorova, C.-C. Kao, T.-S. Chu, T.-J. Tsai, K.-D. Wu, M.-S. Wu, V. Raikou, P. Kaisidis, E. Tsamparlis, P. Kanellopoulos, J. Boletis, A. Ueda, A. Hirayama, S. Owada, K. Nagai, C. Saito, and K. Yamagata

Subjects
03 medical and health sciences, Transplantation, medicine.medical_specialty, 0302 clinical medicine, Nephrology, business.industry, 030232 urology & nephrology, medicine, 030204 cardiovascular system & hematology, Intensive care medicine, Dialysis (biochemistry), business, Pathophysiology
Published
2014
Full Text
View/download PDF

2. Cutaneous Mycobacterium chelonae infection distal to the arteriovenous fistula

Author

Laura Labriola, Michel Jadoul, Grégory Van Ingelgem, Charlotte Van Ende, R. Cuvelier, Frédéric Lecouvet, Dunja Wilmes, UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale, UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de radiologie, UCL - (SLuc) Service de médecine interne générale, and UCL - (SLuc) Service de néphrologie

Subjects
0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, 030106 microbiology, 030232 urology & nephrology, Mycobacterium chelonae, Arteriovenous fistula, Skin infection, 03 medical and health sciences, 0302 clinical medicine, Biopsy, medicine, arteriovenous fistula, Transplantation, medicine.diagnostic_test, biology, business.industry, Incidence (epidemiology), medicine.disease, biology.organism_classification, Surgery, haemodialysis, Nephrology, Hemodialysis, Presentation (obstetrics), business, Vascular Access, Tissue biopsy
Abstract

A few single cases of Mycobacterium chelonae skin infection have been reported in haemodialysis patients. We report three additional cases that share peculiar clinical characteristics, pointing to diagnostic clues. All three cases presented as erythematous nodules developing distally to a proximal arteriovenous fistula (AVF). This presentation was identical to that of two published cases. A survey of all Belgian haemodialysis units during the period 2007-11 yields an estimated incidence of ∼0.9/10 000 patient-years. Although the source of M. chelonae remains unclear, this specific clinical presentation should be added to the listing of potential complications of an AVF and should be recognized, as it is fully treatable if diagnosed by culture and tissue biopsy.

Published
2016

3. Three cases of opportunistic infection caused by propionic acid producingCorynebacterium minutissimum

Author

Georges Wauters, E. Serruys, B. Van Bosterhaut, R. Cuvelier, and F. Pouthier

Subjects
Male, Microbiology (medical), medicine.drug_class, Opportunistic infection, medicine.medical_treatment, Antibiotics, Drug resistance, Corynebacterium, Opportunistic Infections, Corynebacterium minutissimum, Peritoneal dialysis, Microbiology, Corynebacterium jeikeium, medicine, Humans, Prolymphocytic leukemia, Aged, Corynebacterium Infections, biology, business.industry, Drug Resistance, Microbial, General Medicine, Middle Aged, biology.organism_classification, medicine.disease, Leukemia, Infectious Diseases, Female, Propionates, business
Abstract

Propionic acid producing strains of Corynebacterium minutissimum were isolated from three patients with opportunistic infections. One neutropenic patient was undergoing chemotherapy for prolymphocytic leukemia; the other two patients were undergoing hemodialysis and peritoneal dialysis respectively. An unusual feature of these three strains was their resistance to several antibiotics, which is seldom seen in diphtheroids other than Corynebacterium jeikeium and CDC group D2.

Published
1992
Full Text
View/download PDF

4. Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis

Author

Véronique Avesani, Georges Wauters, B. Van Bosterhaut, Jacqueline Charlier, Michel Delmée, R. Cuvelier, Michèle Janssens, and UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique

Subjects
Microbiology (medical), Brevibacteriaceae, medicine.medical_specialty, medicine.medical_treatment, Peritonitis, Case Reports, Brevibacterium otitidis, Peritoneal dialysis, Peritoneal Dialysis, Continuous Ambulatory, medicine, Brevibacterium, Humans, Dialysis, Gram-Positive Bacterial Infections, Aged, biology, business.industry, Continuous ambulatory peritoneal dialysis, medicine.disease, biology.organism_classification, Surgery, Ambulatory, Female, sense organs, business
Abstract

Brevibacterium otitidis is a coryneform rod and, as far as is known, is isolated only from infected ears. We report the first known case of peritonitis caused by B. otitidis in a patient undergoing continuous ambulatory peritoneal dialysis.

Published
2000

5. ACE inhibitors and anaphylactoid reactions to high-flux membrane dialysis

Author

Pierre Dupont, R. Cuvelier, C. Richard, A. Blumberg, R. Wens, F. Dehout, J.C. Stolear, C. A. Dinarello, J. F. de Fremont, Jean-Louis Vanherweghem, Mario Espinosa, M.A. Alvarez-Lara, D. Castillo, Alejandro Martin-Malo, Christian Tielemans, and Pedro Aljama

Subjects
medicine.medical_specialty, Resuscitation, business.industry, Synthetic membrane, Membrane filter, General Medicine, Surgery, High flux, Membrane, Anesthesia, medicine, Anaphylactoid reactions, business, Dialysis (biochemistry)
Published
1991
Full Text
View/download PDF

7. Site of action of torasemide in man

Author

P. Pellegrin, Michel Lesne, Charles van Ypersele de Strihou, and R. Cuvelier

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Natriuresis, Urine, Electrolytes, Chlorides, Internal medicine, medicine, Loop of Henle, Humans, Pharmacology (medical), Diuretics, Osmotic diuresis, Pharmacology, Sulfonamides, Chemistry, Osmolar Concentration, Furosemide, Water, General Medicine, Torsemide, Diuresis, Free water clearance, medicine.anatomical_structure, Endocrinology, Kidney Tubules, Renal physiology, Female, Diuretic, Site of action, medicine.drug, Glomerular Filtration Rate
Abstract

The effect of torasemide, a new orally and parenterally active diuretic agent, on the renal mechanisms of dilution and concentration was studied in 6 healthy volunteers. The experimental conditions included water and osmotic diuresis. Torasemide caused maximal chloruresis and natriuresis during the 20–40 min after administration. The effect was more pronounced under osmotic diuresis and persisted throughout the 100 min of those experiments. A distinct effect both on free water clearance ( $$CL_{H_2 0}$$ ) during water diuresis and tubular reabsorption of solute free water ( $$T_{cH_2 0}$$ ) during osmotic diuresis strongly suggests that the major site of action of torasemide is the ascending limb of the loop of Henle. Comparison with furosemide under osmotic diuresis indicates longer abolition of $$T_{cH_2 0}$$ /GFR by torasemide in keeping with the fact that its half-life is 2- to 3-times longer than that of furosemide.

Published
1986

8. Late urinary tract infection after transplantation: prevalence, predisposition and morbidity

Author

Charles van Ypersele de Strihou, Guy P. Alexandre, Yves Pirson, and R. Cuvelier

Subjects
Adult, Male, medicine.medical_specialty, business.industry, Urinary system, Incidence (epidemiology), Graft Survival, Urology, Prognosis, Kidney Transplantation, Transplantation, surgical procedures, operative, Postoperative Complications, Actuarial Analysis, Internal medicine, Urinary Tract Infections, medicine, Humans, Female, business, Follow-Up Studies
Abstract

We have evaluated the incidence, prevalence, predisposing factors and evolution of urinary tract infection (UTI) developing late after transplantation in 63 patients whose graft had lasted at least 3 months and whose follow-up averaged 7 years. Beyond 3 months after transplantation incidence of UTI decreases progressively, from 25 to 0%, 50% of the patients remaining free of infection throughout the period of observation. Neither the original kidney disease except perhaps diabetic nephropathy nor the presence of vesicoureteral reflux were predisposing factors. Incidence and prevalence in females were twice that in male. Late UTI did not affect graft or patient survival, or graft function at 5 years. Most UTI were asymptomatic and had a benign course. However, in 3 patients septicemia or graft dysfunction ensued demonstrating the need for continuous monitoring of urine cultures.

Published
1985

10. Beneficial Effect of Desferrioxamine on the Anaemia of a Haemodialysis Patient without Aluminium or Iron Overlaod

Author

R. Cuvelier, G. Mouligneau, and P. Deceuninck

Subjects
medicine.medical_specialty, chemistry, Aluminium, business.industry, Internal medicine, medicine, chemistry.chemical_element, business, Gastroenterology, Serum ferritin
Abstract

Desferrioxamine (DFO) has been proved to be effective in the traetment of the anaemia of haemodialysis (H D) patients with aluminium (A1) (1) or iron (2) overload. We report the beneficial effect of DFO (Desfera1, Ciba) on the anaemia of a 62-year-old woman treated for 3 years by HD in whom we found no evidence of A1 or iron over load.

Published
1989
Full Text
View/download PDF

11. [Kidney transplantation in a case of amyloidosis]

Author

R, Cuvelier, Y, Pirson, J P, Cosyns, J P, Squifflet, G P, Alexandre, and C, van Ypersele de Strihou

Subjects
Adult, Male, Postoperative Complications, Adolescent, Recurrence, Humans, Kidney Failure, Chronic, Female, Kidney Diseases, Amyloidosis, Kidney Transplantation
Abstract

Renal transplantation was performed in five patients with various forms of amyloidosis (familial amyloidosis, Mediterranean fever and Crohn's disease). All grafts were functioning one year after the operation. Only one patient died of cardiac shock more than 10 years after transplantation; the other recipients are alive with a functioning graft from 12 to 67 (mean, 41) months after transplantation. No early severe infection was observed in any patient. Graft biopsy obtained in three patients disclosed amyloid deposits in only one: deposits initially (72 months post-transplantation) mild and perivascular, became more prominent in the vessels and extended into the mesangium 4 1/2 years later. Extrarenal amyloid involvement observed in four cases did not lead to serious clinical consequences during the follow-up period. Renal transplantation thus provides an effective treatment of terminal renal failure due to amyloidosis whatever its cause.

Published
1986

12. [Biochemical study of bronchial sputum]

Author

C, GERNEZ-RIEUX, G, BISERTE, R, HAVEZ, C, VOISIN, and R, CUVELIER

Subjects
Carcinoma, Bronchogenic, Bronchial Neoplasms, Carcinoma, Smoking, Sputum, Transferrin, Humans, Neuraminic Acids, Bronchitis, Asthma, Glycoproteins, Glycosaminoglycans
Published
1963

31. [THE GLYCOPROTEINS OF BRONCHIAL SECRETIONS]

Author

G, BISERTE, R, HAVEZ, and R, CUVELIER

Subjects
Electrophoresis, Chromatography, Mucous Membrane, Pentoses, Beta-Globulins, Sputum, Transferrin, Hexosamines, Antibodies, Asthma, Pepsin A, Mucus, Renal Dialysis, Blood Group Antigens, Chymotrypsin, Humans, Urea, Neuraminic Acids, Serum Globulins, Trypsin, Bronchitis, Dialysis, Immunoelectrophoresis, Fucose, Glycoproteins
Published
1963

32. [HURLER'S DISEASE IN AN INFANT: CYTOLOGICAL AND BIOCHEMICAL STUDY]

Author

L, CHRISTIAENS, R, WALBAUM, J P, FARRIAUX, and R, CUVELIER

Subjects
Blood Protein Disorders, Fructose-Bisphosphate Aldolase, Mucopolysaccharidosis I, Humans, Infant, Urea, Bone Marrow Examination, Aspartate Aminotransferases, Clinical Enzyme Tests, Immunoelectrophoresis, Blood Cell Count, Glycoproteins
Published
1964

38. [Research on blood lipid changes during hydrotherapy with sodium bicarbonate]

Author

R, Cuvelier, P, Tronche, J L, Aublet-Cuvelier, and F, Walter

Subjects
Adult, Male, Fatty Acids, Essential, Gout, Arteriosclerosis, Biliary Tract Diseases, Hypercholesterolemia, Sodium, Fatty Acids, Nonesterified, Middle Aged, Lipids, Bicarbonates, Cholesterol, Diabetes Mellitus, Humans, Female, Obesity, Mineral Waters, Phospholipids, Triglycerides, Aged, Hydrotherapy
Published
1972

Catalog

Books, media, physical & digital resources
See catalog results